Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
about
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants.
P2860
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@en
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@nl
type
label
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@en
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@nl
prefLabel
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@en
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@nl
P2093
P1433
P1476
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.
@en
P2093
Devayani Kolhe
Karin Hardt
Olivier Van Der Meeren
Sherine Kuriyakose
P304
P356
10.1016/J.VACCINE.2012.02.024
P407
P577
2012-02-18T00:00:00Z